JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB102899

PE/Cy5.5® Conjugation Kit - Lightning-Link®

Be the first to review this product! Submit a review

|

(10 Publications)

PE/Cy5.5® Conjugation Kit - Lightning-Link® (ab102899) offers several standout features:

- Rapid Conjugation: achieve PE/Cy5.5 labeling in under 4 hours with just 30 seconds of hands-on time.
- High Efficiency: ensures 100% antibody recovery, meaning no loss of valuable antibodies.
- Versatility: suitable for conjugating antibodies, proteins, and peptides. PE/Cy5.5 labeled antibodies can be used immediately in applications such asFlow cytometry, ELISA, and Immunohistochemistry (IHC) without further purification.
3 Images
Flow Cytometry - PE/Cy5.5® Conjugation Kit - Lightning-Link® (AB102899)
  • Flow Cyt

PubMed

Sancey, Lucie, et al used PE/Cy5.5® Conjugation Kit - Lightning-Link® (ab102899) as part of examining AGuIX NP uptake measured by FCM as a function of time in the 3 OncoCilAir™ subpopulations. They used the kit to conjugate PE/Cy5.5® to IgG isotype control antibody for use in flow cytometry.
a Summary of AGuIX® uptake with the percentage of AGuIX®+ cells and their corresponding MFI values presented after 24 and 72 h of NP exposure (n=6/conditions, from 3 distinct batches of cell culture with and without mucus). The relative uptake ratios were calculated from Eq. 3. Statistical analysis was performed using the Mann-Whitney test (*p 0.05 compared to GFP-negative cells). The results b-i were obtained from samples of the 2nd series of cell cultures, presenting a fast tumor growth and an intense AGuIX® uptake at T24h. FACS plots of AGuIX® uptake (% of AGuIX+-cells and geometric mean MFI) according to the 3 gates (b, f) that discriminate GFP-negative (red channel; c, g), GFP+ (green channel; d, h) and GFP++ (blue channel; e, i) tumor cells at 24 h (b-e) and 72 h (f-i)

Image from Sancey, Lucie, et al., J. nanobiotechnology, 18(1):129; doi: 10.1186/s12951-020-00683-6. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Schematic Diagram - PE/Cy5.5® Conjugation Kit - Lightning-Link® (AB102899)
  • Schematic Diagram

Supplier Data

This illustration demonstrates a general procedure of how Lightning-Link® labeling technology enables the direct labeling of antibodies or proteins.

Simply pipette your antibody or biomolecule of choice into the vial of a lyophilized mixture containing the label of interest and incubate for around 3 hours. Please see the ab102899 protocol booklet for more details.

Learn more about our Lightning-Link® conjugation kits here

Flow Cytometry - PE/Cy5.5® Conjugation Kit - Lightning-Link® (AB102899)
  • Flow Cyt

PubMed

Wang, Shuyan, et al used PE/Cy5.5® Conjugation Kit - Lightning-Link® (ab102899) as part of examining Neph3-positive cells co-cultured with rat cerebellar slices. They used the kit to conjugate PE/Cy5.5® to anti-Neph3 monoclonal antibody for use in flow cytometry.
(A) Schematic representation of sorting and co-culture procedures. (B, C) FACS analysis of neural rosette cells on Day 20 of differentiation. (D) Immunofluorescence staining to confirm that the sorted cells were Neph3/GFP-double positive. Bar = 100 μm. (E) The sorted cells were co-cultured with cerebellum slices and examined at 1 week and 4 weeks. Bar = 100 μm.

Image from Wang, Shuyan, et al., Scientific reports, 5:9232; doi: 10.1038/srep09232. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Key facts

Product details

PE/Cy5.5® Conjugation Kit - Lightning-Link® (ab102899) uses a simple and quick process for PE/Cy5.5 labeling / conjugation of antibodies. It can also be used to conjugate other proteins or peptides.

To conjugate an antibody to PE/Cy5.5® using this kit:
- add modifier to antibody and incubate for 3 hrs
- add quencher and incubate for 30 mins

The PE/Cy5.5® conjugated antibody can be used immediately in Flow cytometry and other applications. No further purification is required and 100% of the antibody is recovered for use.

Learn about our antibody labeling kits and their advantages here.

Learn about buffer compatibility below; for incompatible buffers and low antibody concentrations, use our antibody purification and concentration kits.
Custom size conjugation kits up to 100 mg are available on demand. Please contact us to discuss your requirements.

Amount and volume of antibody for conjugation to PE/Cy5.5®.

Kit size Recommended
amount of antibody
Maximum antibody
volume1
3 x 10 µg 3 x 10 µg 3 x 10 µL
60 µg 1 x 60 µg 1 x 60 µL
3 x 60 µg 3 x 60 µg 3 x 60 µL
600 µg 1 x 600 µg 1 x 600 µL

1Ideal antibody concentration is 1mg/mL. 0.5 - 1 mg/mL can be used if the maximum antibody volume is not exceeded. Antibodies > 1 mg/mL or < 0.5 mg/mL should be diluted /concentrated.

The selling size of this product has been changed – it is now based on the amount of antibody that can be conjugated with the kit, not the amount of PE mix provided. The amount of antibody advised that can be used with the kit has also been updated to reflect what will give the best conjugation results. The quantity and formulation of reagents provided have not changed, if you have been previously using the kit successfully with a different amount of antibody, there is no need to change the way that you are using the kit.

Buffer Requirements for Conjugation

Buffer should be pH 6.5-8.5.

Compatible buffer constituents
If a concentration is shown, then the constituent should be no more than the concentration shown. If several constituents are close to the limit of acceptable concentration, then this can inhibit conjugation.

50mM / 0.6% Tris1 0.1% BSA 50% glycerol
0.1% sodium azide PBS Potassium phosphate
Sodium chloride HEPES Sucrose
Sodium citrate EDTA Trehalose

1 Tris buffered saline is almost always ≤ 50 mM / 0.6%

Incompatible buffer constituents

Thiomerosal Proclin Glycine
Arginine Glutathione DTT

If a constituent of the buffer containing your antibody or protein is not listed above, please contact us.

Only purified antibodies are suitable for use, ie. where other proteins, peptides, or amino acids are not present: antibodies in ascites fluid, serum or hybridoma culture media are incompatible.

Storing and handling conjugation kits

Lyophilized Lightning-Link® components are hygroscopic.

Kits are intentionally shipped at ambient temperature with silica gel to avoid exposure to moisture. Upon receipt, store the kit frozen and protect from moisture. Before opening the outer container, allow the lyophilized components to reach room temperature to minimize condensation.

This product is manufactured by Expedeon, an Abcam company, and was previously called Lightning-Link® R-PE/Cy5.5 Labeling Kit. 761-0005 is the same as the 60 µg size. 761-0010 is the same as the 3 x 60 µg size. 761-0030 is the same as the 3 x 10 µg size. 761-0015 is the same as the 600 µg size.

What's included?

{ "values": { "60g": { "sellingSize": "60 µg", "publicAssetCode":"ab102899-60ug", "assetComponentDetails": [ { "size":"1 x 60 µg", "name":"PE/Cy5.5 mix", "number":"AB102899-CMP02" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB102899-CMP01" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB102899-CMP03" } ] }, "600g": { "sellingSize": "600 µg", "publicAssetCode":"ab102899-600ug", "assetComponentDetails": [ { "size":"1 x 600 µg", "name":"PE/Cy5.5 mix", "number":"AB102899-CMP02" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB102899-CMP01" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB102899-CMP03" } ] }, "3x60g": { "sellingSize": "3 x 60 µg", "publicAssetCode":"ab102899-3x60ug", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB102899-CMP03" }, { "size":"3 x 60 µg", "name":"PE/Cy5.5 mix", "number":"AB102899-CMP02" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB102899-CMP01" } ] }, "3x10g": { "sellingSize": "3 x 10 µg", "publicAssetCode":"ab102899-3x10ug", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB102899-CMP01", "productcode":"" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB102899-CMP03", "productcode":"" }, { "size":"3 x 10 µg", "name":"PE/Cy5.5 mix", "number":"AB102899-CMP02", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Ambient - Cannot Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
-20°C

Product protocols

Target data

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Current protocols 2:e589 PubMed36373983

2022

Do more with Less: Improving High Parameter Cytometry Through Overnight Staining.

Applications

Unspecified application

Species

Unspecified reactive species

Carly E Whyte,Damon J Tumes,Adrian Liston,Oliver T Burton

Cell reports 34:108863 PubMed33691089

2021

Metabolic programs define dysfunctional immune responses in severe COVID-19 patients.

Applications

Unspecified application

Species

Unspecified reactive species

Elizabeth A Thompson,Katherine Cascino,Alvaro A Ordonez,Weiqiang Zhou,Ajay Vaghasia,Anne Hamacher-Brady,Nathan R Brady,Im-Hong Sun,Rulin Wang,Avi Z Rosenberg,Michael Delannoy,Richard Rothman,Katherine Fenstermacher,Lauren Sauer,Kathyrn Shaw-Saliba,Evan M Bloch,Andrew D Redd,Aaron A R Tobian,Maureen Horton,Kellie Smith,Andrew Pekosz,Franco R D'Alessio,Srinivasan Yegnasubramanian,Hongkai Ji,Andrea L Cox,Jonathan D Powell

Med (New York, N.Y.) 2:243-262.e8 PubMed33521747

2021

A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice.

Applications

Unspecified application

Species

Unspecified reactive species

Alyssa Silva-Cayetano,William S Foster,Silvia Innocentin,Sandra Belij-Rammerstorfer,Alexandra J Spencer,Oliver T Burton,Sigrid Fra-Bidó,Jia Le Lee,Nazia Thakur,Carina Conceicao,Daniel Wright,Jordan Barrett,Nicola Evans-Bailey,Carly Noble,Dalan Bailey,Adrian Liston,Sarah C Gilbert,Teresa Lambe,Michelle A Linterman

medRxiv : the preprint server for health sciences : PubMed32935120

2020

Metabolic programs define dysfunctional immune responses in severe COVID-19 patients.

Applications

Unspecified application

Species

Unspecified reactive species

Elizabeth A Thompson,Katherine Cascino,Alvaro A Ordonez,Weiqiang Zhou,Ajay Vaghasia,Anne Hamacher-Brady,Nathan R Brady,Im-Hong Sun,Rulin Wang,Avi Z Rosenberg,Michael Delannoy,Richard Rothman,Katherine Fenstermacher,Lauren Sauer,Kathyrn Shaw-Saliba,Evan M Bloch,Andrew D Redd,Aaron Ar Tobian,Maureen Horton,Kellie Smith,Andrew Pekosz,Franco R D'Alessio,Srinivasan Yegnasubramanian,Hongkai Ji,Andrea L Cox,Jonathan D Powell

Journal of nanobiotechnology 18:129 PubMed32912214

2020

Multiparametric investigation of non functionalized-AGuIX nanoparticles in 3D human airway epithelium models demonstrates preferential targeting of tumor cells.

Applications

Unspecified application

Species

Unspecified reactive species

Lucie Sancey,Odile Sabido,Zhiguo He,Fabien Rossetti,Alain Guignandon,Valérie Bin,Jean-Luc Coll,Michèle Cottier,François Lux,Olivier Tillement,Samuel Constant,Christophe Mas,Delphine Boudard

Cell 182:625-640.e24 PubMed32702313

2020

Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition.

Applications

Unspecified application

Species

Unspecified reactive species

Emanuela Pasciuto,Oliver T Burton,Carlos P Roca,Vasiliki Lagou,Wenson D Rajan,Tom Theys,Renzo Mancuso,Raul Y Tito,Lubna Kouser,Zsuzsanna Callaerts-Vegh,Alerie G de la Fuente,Teresa Prezzemolo,Loriana G Mascali,Aleksandra Brajic,Carly E Whyte,Lidia Yshii,Anna Martinez-Muriana,Michelle Naughton,Andrew Young,Alena Moudra,Pierre Lemaitre,Suresh Poovathingal,Jeroen Raes,Bart De Strooper,Denise C Fitzgerald,James Dooley,Adrian Liston

Genetics in medicine : official journal of the Ame 19:1071-1077 PubMed28301456

2017

Prediction of breast cancer risk based on flow-variant analysis of circulating peripheral blood B cells.

Applications

Unspecified application

Species

Unspecified reactive species

Mahrukh M Syeda,Kinnari Upadhyay,Johnny Loke,Alexander Pearlman,Susan Klugman,Yongzhao Shao,Harry Ostrer

Scientific reports 5:9232 PubMed25782665

2015

Differentiation of human induced pluripotent stem cells to mature functional Purkinje neurons.

Applications

Unspecified application

Species

Unspecified reactive species

Shuyan Wang,Bin Wang,Na Pan,Linlin Fu,Chaodong Wang,Gongru Song,Jing An,Zhongfeng Liu,Wanwan Zhu,Yunqian Guan,Zhi-Qing David Xu,Piu Chan,Zhiguo Chen,Y Alex Zhang

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 26:1301-10 PubMed22121051

2011

Distinctive immunoregulatory effects of adenosine on T cells of older humans.

Applications

Unspecified application

Species

Unspecified reactive species

Charles S Hesdorffer,Enkhzol Malchinkhuu,Arya Biragyn,Omar S Mabrouk,Robert T Kennedy,Karen Madara,Dennis D Taub,Dan L Longo,Janice B Schwartz,Luigi Ferrucci,Edward J Goetzl

Nature medicine 16:446-51 PubMed20208541

2010

HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs.

Applications

Unspecified application

Species

Unspecified reactive species

Christoph C Carter,Adewunmi Onafuwa-Nuga,Lucy A McNamara,James Riddell,Dale Bixby,Michael R Savona,Kathleen L Collins
View all publications
websiteProtocolBooklet
en
websiteProtocolBooklet
zh

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com